These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5038775)

  • 41. [Antioxidants in liver protection].
    Hagymási K; Blázovics A
    Orv Hetil; 2004 Jul; 145(27):1421-5. PubMed ID: 15320484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.
    Zieve L; Doizaki WM; Lyftogt C
    J Lab Clin Med; 1984 Nov; 104(5):655-64. PubMed ID: 6491466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The treatment of alcoholism with metadoxil].
    Iakovlev VA
    Voen Med Zh; 1999 Oct; 320(10):57-9. PubMed ID: 10605344
    [No Abstract]   [Full Text] [Related]  

  • 44. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatic encephalopathy: pathogenesis.
    Bernardini AP
    Arq Gastroenterol; 1988; 25 Spec No():57-61. PubMed ID: 3060059
    [No Abstract]   [Full Text] [Related]  

  • 46. [Metadoxyl in combined treatment of alcohol damage to the liver].
    Vedrova NN; Gnezdilova NIu
    Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of the arginine-ornithine combination on the arterial ammonia levels in chronic liver diseases and hepatic coma].
    Miszputen SJ; Ganc AJ; Costa AA; Reibscheid S; Vilela MP
    AMB Rev Assoc Med Bras; 1968 Jul; 14(7):117-22. PubMed ID: 5304250
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of L-arginine on hepatic encephalopathy.
    FAZEKAS JF; TICKTIN HE; SHEA JG
    Am J Med Sci; 1957 Oct; 234(4):462-7. PubMed ID: 13469810
    [No Abstract]   [Full Text] [Related]  

  • 49. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hepatic encephalopathy].
    Bernardini AP; Silva Ade O
    Arq Gastroenterol; 1984; 20(4):156-65. PubMed ID: 6146302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of metadoxyl in the treatment of the hepatotoxic effects of cytostatics].
    Safonova SA; Gershanovich ML
    Vopr Onkol; 2005; 51(5):599-600. PubMed ID: 16756021
    [No Abstract]   [Full Text] [Related]  

  • 52. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
    Spatz R; Kollmannsberger A
    Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Supplement to the clinical study on the effectiveness of an anticataract preparation].
    Hockwin O; Weigelin E; Baur M
    Fortschr Ophthalmol; 1985; 82(3):237-9. PubMed ID: 3897000
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prognostic factors during coma due to acute hepatic atrophy].
    Caroli J; Opolon P; Scotto J; Hadchouel P; Thomas M; Lageron A
    Presse Med (1893); 1971 Feb; 79(11):463-6. PubMed ID: 5555633
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antiradiation effectiveness of amino acid mixtures of various compositions].
    Lapteva TA; Bezkrovnaia LA
    Radiobiologiia; 1989; 29(3):359-62. PubMed ID: 2762526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis.
    Salerno F; Abbiati R; Fici F
    Int J Clin Pharmacol Res; 1983; 3(1):21-5. PubMed ID: 6679504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats.
    Baldacci M; Catalani R; Bartoli C; Mura U
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788
    [No Abstract]   [Full Text] [Related]  

  • 60. N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.
    Lee JH; Kim WH; Cho H; Kwak YS; Kim S; Paik WK
    Biochem Biophys Res Commun; 1998 Jul; 248(2):391-4. PubMed ID: 9675147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.